For Media

Tools & Tips

Adding free, full-text links to your stories

JAMA Network Media Relations provides links to journalists that can be embedded in news stories to provide their readers with free, full-text access to published studies. The links have special codes allowing up to four months of public access.  These links can be found in news releases, and will go live at publication time.

Reporting by topic and specialty

In addition to regular JAMA Network Media Center emails, reporters with active credentials can opt into additional email newsletters.

At this page, under “Manage Email,” click “Change your email preferences.”

All journals have regular newsletters that include recently published content.

Additionally, JAMA Network offers curated themed newsletters: Women’s Health, AI in Medicine, Equity, and Health Policy. Reporters may find these to be helpful resources.

Finally, the JAMA Network Media Relations team collects reporter beat focus during applications. We use this data to perform our own embargoed curated outreach. Be sure to select the beats relevant to your role during your application.  

Medical journal glossary

What is the difference between a randomized clinical trial and an observational study? How does a Viewpoint differ from a Perspective ?

Familiarize yourself with medical journal terminology and terms specific to JAMA and the JAMA Network with this glossary.

Your Media Center account: How to apply, when to renew, and how to change your email

Sign up for access to the JAMA Media Center by creating an account. Once your account has been created, you will apply for access. A member of the JAMA Media Relations team will review your application.

Credentialed users will need to reapply annually to renew access. One month prior to expiration, users will receive a reminder email with a link to renew.

If you already have an account but need to update your email address, do so here.

If you have questions about your account, email mediarelations@jamanetwork.org.

Contacting authors for interviews

All releases in the “Latest Articles” section of the JAMA Media Center include the corresponding author’s name, contact information, and institution.

Note that most articles have more than one author, and Original Investigations are frequently accompanied by outside commentary. These authors can provide additional perspectives for your stories.

We encourage reporters to include the press officers from authors’ respective institutions on interview request outreach. 

Embargo Policy

What does it mean if information is “embargoed”?

A media embargo means that study information cannot be published, broadcast, posted online, shared with non-journalists or otherwise be made public until the article is published on JAMA Network websites. This includes reporting that a JAMA Network journal will publish a study in the future.

What is the embargo policy of JAMA and JAMA Network Journals?

JAMA Network allows eligible members of the media to access articles two business days prior to publication, provided reporters agree not to publish, broadcast, post online, or otherwise share the content until it appears on JAMA Network websites.

During the 48-hour embargo period, journalists may contact authors for interviews  and consult with other experts to prepare coverage for release when the article is published.

We encourage reporters to embed into their stories the links we provide in our releases. These will go live at publication time and provide readers free full-text access to the research.

For more on medical journal embargoes, see this Recommendation Statement from the International Committee of Medical Journal Editors.

Embargo Times

Embargoes vary and lift the time and day articles are published online.

The regular schedule of which journals publish content on which days is:

Monday

JAMA, JAMA Network Open, JAMA Internal Medicine, JAMA Neurology, JAMA Pediatrics

Tuesday

JAMA Network Open

Wednesday

JAMA, JAMA Network Open, JAMA Cardiology, JAMA Dermatology, JAMA Psychiatry, JAMA Surgery

Thursday

JAMA, JAMA Network Open, JAMA Oncology, JAMA Ophthalmology, JAMA Otolaryngology-Head & Neck Surgery

Friday

JAMA, JAMA Network Open, JAMA Health Forum

If a holiday falls during the work week, the posting of embargoed content will be shifted to allow two working business days of embargoed access. (I.e.,  during the week of Labor Day, Wednesday content will be posted under embargo the prior Friday).

Additionally, JAMA Network editors publish content outside the regular schedule in correlation with scientific conferences. Those items will appear on the JAMA Network Media Center, and embargo times will be set by the meetings.

What happens if a reporter breaks an embargo?

JAMA Network Media Relations reviews embargo breaks on a case-by-case basis. Circumstances of the embargo violation will be evaluated before a determination is made. Penalties for breaking an embargo may include, but are not limited to, loss of access to embargoed materials. The reporter’s media outlet may also be penalized.

If a media outlet/reporter has been suspended, it will be the responsibility of the reporter and media outlet to reapply for access to embargoed materials after the suspension period ends.

Who can access embargoed content?

JAMA Network will grant credentials to:

  • Reporters, writers, editors, and producers from newspapers, magazines, online news outlets, wire services, radio or television networks and stations.

  • Reporters, writers, editors, and producers for trade media (i.e., B2B outlets) evaluated on a case-by-case basis. Staff must demonstrate that they work solely on editorially independent “earned” media and are not involved in paid or sponsored content.

  • Independent journalists and editors who regularly cover health-related topics Note: Individuals will be required to provide examples of recent work

  • Representatives of academic, government, or hospital media relations departments

Media credentials are not transferable. Each person accessing the site must have their own credentials.

The following are not eligible for embargoed media access:

  • Public relations firms and advertising agencies

  • Employees of companies or any organization with a commercial interest in study findings

  • Contributors to patient publications produced by pharmaceutical, device, or other private companies

  • Financial or industry analysts

  • Publications or websites funded by industry, including those run by advocacy groups

  • Representatives from corporate public relations, advertising, or marketing departments

Editor's Picks